|
91 |
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial |
Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators. |
Circulation |
2019 |
|
92 |
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial |
Szarek M, Steg PG, DiCenso D, Bhatt DL, Bittner VA, Budaj A, Diaz R, Goodman SG, Gotcheva N, Jukema JW, Pordy R, Roe MT, Sourdille T, White HD, Xavier D, Zeiher AM, Schwartz GG |
Circ Cardiovasc Qual Outcomes |
2019 |
|
93 |
Prescription Pattern, Short-Term Outcomes, and Its Determinants in Patients With Chronic Kidney Disease Attending a Tertiary Care Hospital |
Mamadi RK, Sathish R, Selvaraj DR, Rathore R, Jose JV, Xavier D |
Indian J Pharmacol |
2019 |
|
94 |
Prescription Pattern, Short-Term Outcomes, and Its Determinants in Patients With Chronic Kidney Disease Attending a Tertiary Care Hospital |
Mamadi RK, Sathish R, Selvaraj DR, Rathore R, Jose JV, Xavier D |
Indian J Pharmacol |
2019 |
|
95 |
The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017. |
K Balakrishnan, S Dey, T Gupta, RS Dhaliwal, M Brauer, AJ Cohen, *D Xavier*, et al.. |
The Lancet Planetary Health |
2019 |
|
96 |
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial |
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, *Pais P*, *Xavier D*, Atisso CM, et al.. |
The Lancet |
2019 |
|
97 |
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. |
Kausik K Ray, Helen M Colhoun, Michael Szarek, Marie Baccara-Dinet, *Denis Xavier*, et al.. |
The Lancet Diabetes and Endocrinology |
2019 |
|
98 |
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial |
Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, Xavier D, Szczeklik W, Meyhoff CS, et al; MANAGE Investigators |
Lancet |
2018 |
|
99 |
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 |
Fullman N, Yearwood J, Abay SM, Abbafati C, Abd-Allah F, Abdela J, Xavier D, et al; GBD 2016 Healthcare Access and Quality Collaborators |
Lancet |
2018 |
|
100 |
First Stroke Reduced 44 Percent by Well Tolerated Medications. Stroke Outcomes From the Heart Outcomes Prevention Evaluation 3 Study |
Bosch J, Lonn E, Zhu J, Pais P, Xavier D, Dans A, Diaz R, Hart R, Yusuf S |
Stroke |
2018 |
|
101 |
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct |
Joseph P, Pais P, Dans AL, Bosch J, Xavier D, Lopez-Jaramillo P, Yusoff K, Santoso A, Talukder S, Gamra H, Yeates K, Lopez PC, Tyrwhitt J, Gao P, Teo K, Yusuf S; TIPS-3 Investigators |
Am Heart J |
2018 |
|
102 |
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial |
Szarek M, White HD, Schwartz GG, Alings M, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Kimura T, Kiss RG, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Tricoci P, Xavier D, Zeiher AM, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. |
J Am Coll Cardiol |
2018 |
|
103 |
Treadmill stress tests should not be part of "routine health check package" |
Pais P |
Indian Heart Journal |
2018 |
|
104 |
Low quality cardiovascular care is important coronary risk factor in India |
Gupta R, Khedar RS, Gaur K, Xavier D |
Indian Heart Journal |
2018 |
|
105 |
Effect of intensive lifestyle modification & metformin on cardiovascular risk in prediabetes: A pilot randomized control trial |
Kulkarni S, Xavier D, George B, Umesh S, Fathima S, Bantwal G |
Indian J Med Res |
2018 |